Lisata Therapeutics, Inc.

US$1.03As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LSTAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (33.53%)
Div yield —
ROE (101.66%)
Biotechnology
Beta (5Y) 1.02
PE TTM —
TSR TTM (63.08%)
Mkt cap US$9.281M
ROIC (71.26%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.17
13.80%
34.32%
Hold 3|4|11|3|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
8.18%
10.69%
6.01%
23.39%
Revenue$M
0.600
0.586
0.601
0.617
(1.11%)
(3.32%)
(0.16%)
1.90%
Peers (US$9.281M)
Cap (US$)
PE
9.286M
—
9.314M
2.652x
Capital
TTM
5Y
10Y
Leveragex
0.922
0.183
0.141
EBIT/Intx
1.388
0.894
0.778
Own earn%
(177.57)
(6.44)
(9.81)
Sh yield%
48.48
39.37
38.97
Owners
Insiders/Inst%
8.91
30.01
Short interest%
2.27
SBC / revenue%
4.10
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
23–28
$1 testx
—
Incr. ROIC%
58